Clinical Trial Update: Mechanisms of Erythropoietin Action in the Cardiorenal Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update examining the mechanisms of erythropoietin action in the cardiorenal syndrome; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Heart Failure

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: UMC Utrecht | Conditions: Heart Failure, Congestive, Renal Insufficiency, Chronic | Phase 3 | Status: COMPLETED